• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine. Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine.

Giuseppe

Emeritus
Vaccine. 2008 Dec 26. [Epub ahead of print]

Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine.

Coucke D, Schotsaert M, Libert C, Pringels E, Vervaet C, Foreman P, Saelens X, Remon JP. - Laboratory of Pharmaceutical Technology, Ghent University, Ghent, Belgium.

Mucosal vaccination has several advantages over parenteral vaccination.
In this study, viscosity-enhancing mucosal delivery systems for the induction of an adaptive immune response against viral antigen were investigated.
Powder formulations based on spray-dried mixtures of starch (Amioca((R)))/poly(acrylic acid) (Carbopol((R)) 974P) in different ratios were used as carriers of the viral antigen.
A comparison of these formulations for intranasal delivery of heat-inactivated influenza virus combined with LTR192G adjuvant was made in vivo in a rabbit model.
Individual rabbit sera were tested for seroconversion against hemagglutinin (HA), the major surface antigen of influenza.
The powder vaccine formulations were able to induce systemic anti-HA IgG responses.
The presence of Carbopol((R)) 974P improved the kinetics of the immune responses and the level of IgG titers in a dose-dependent way which was due to moderately irritating capacities checked of the formulation.
In contrast, mucosal IgA responses were not detected.
In conclusion, it was demonstrated that the use of bioadhesive carriers based on Amioca((R)) starch and poly(acrylic acid) facilitates the induction of a systemic anti-HA antibody response after intranasal vaccination with a whole virus influenza vaccine.

PMID: 19114075 [PubMed - as supplied by publisher]
-
------
 
Back
Top